top of page

Regulatory Blog

The Regulatory News you Need to Know,Share & Grow

Nov 162 min read

USFDA Guidance: Nonclinical Safety Assessment of Oligonucleotide-Based Therapeutics

This USFDA draft guidance" Nonclinical Safety Assessment of Oligonucleotide-Based Therapeutic s" , issued on 15 November 2024, offers...

14 views0 comments

bottom of page